Targeted mRNA degradation in Drosophila spermatogenesis
Targeted mRNA degradation in Drosophila spermatogenesis
批准号:
BB/I007989/1
负责人:
Sarah Newbury
金额:
$55.21万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Stem cells have a vast potential in regenerative medicine for the replacement of defective tissue. They therefore offer a potential cure for injuries and also for degenerative diseases such as Alzheimers and Duchenne muscular dystrophy. In the testis, stem cells are required to maintain the supply of sperm, so that the male has potential to produce offspring for much of his life. In recent years, there have been rapid advances in the understanding of the genes which are required to be switched ON to produce self-renewing stem cells that are capable of developing into a wide range of tissues e.g. skin or nervous tissue. However, it is now known that it is also crucially important to make sure that certain genes are switched OFF to prevent stem cells from spontaneously differentiating into particular cell types or developing into cancer cells. We have recently discovered that an enzyme named Pacman, which is involved in the destruction of messenger RNA molecules, is necessary for stem cell function in testis cells of the fruit fly Drosophila. Messenger RNAs are the molecules which instruct the cell to make particular proteins. By comparing mutant flies with normal flies, we have found out that there are fewer testis stem cells in the pacman mutant leading to fewer sperm and offspring. Using various genetic and molecular techniques we have found out that Pacman is likely to destroy particular RNAs that would otherwise prevent stem cell division or cell death. This is interesting as it shows that these mRNAs must somehow be 'tagged' allowing Pacman and its partners to identify, 'hunt down' and destroy these particular RNAs. The specific aim of this project is to understand, in molecular terms, exactly how Pacman and its partners can identify and destroy its correct target RNAs and how this is controlled. The ability of Pacman to selectively destroy target RNAs is not intrinsic to itself as isolated Pacman protein in the test tube cannot distinguish between different RNAs. We know that different RNAs are selected in different tissues so how does Pacman and its partners do this? Our hypothesis is that a particular protein (or a tiny regulatory RNA) binds to a specific feature or the target RNA and 'tags' it for destruction. This tag is then recognised by Pacman and its partner proteins. We propose that Pacman, which is a large protein, can act as a scaffold to assemble other proteins upon it. When the correct partners are assembled, in the correct 3-dimensional shape, then a decapitation enzyme snips off the end of the RNA and the rest is rapidly chewed up. In this project, we aim to find out the details of this destruction pathway, including the ways that the target is tagged. This work will increase our general understanding of the ways that genes are specifically switched off in response to their cellular context. Since Pacman is known to be important in other important cellular events such as wound healing and migration of cell sheets, this work may also shed light on the molecular mechanisms of these processes. Although this project will be carried out using the fruit fly Drosophila, it also has relevance for stem cell function in humans as the cellular processes are surprisingly similar in both organisms. In addition, the Pacman enzyme is extremely similar between flies and humans therefore the insights we gain during this project may help us to improve treatment for fertility and also help us to understand the ways that stem cells remain virtually immortal for the lifetime of the organism. This project will therefore provide valuable insights into the ways in which specific RNAs are targeted in a particular cell type which can be used in the development of new therapeutics.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/bjc.2012.525
发表时间:
2012-12-04
期刊:
BRITISH JOURNAL OF CANCER
影响因子:
8.8
作者:
[Jones, C. I., Zabolotskaya, M. V., King, A. J., Stewart, H. J. S., Horne, G. A., Chevassut, T. J., Newbury, S. F.]
通讯作者:
Newbury, S. F.
DOI:
10.3389/fimmu.2017.01977
发表时间:
2017
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Caserta S, Mengozzi M, Kern F, Newbury SF, Ghezzi P, Llewelyn MJ]
通讯作者:
Llewelyn MJ
DOI:
10.3390/biom8020021
发表时间:
2018-04-26
期刊:
Biomolecules
影响因子:
5.5
作者:
[Mumford SL, Towler BP, Pashler AL, Gilleard O, Martin Y, Newbury SF]
通讯作者:
Newbury SF
DOI:
10.1093/nar/gkv1336
发表时间:
2016-01-08
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Jones CI, Pashler AL, Towler BP, Robinson SR, Newbury SF]
通讯作者:
Newbury SF
The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease.
3'至5'驱虫核酸酶dis3:从结构和机制到生物学功能以及在人类疾病中的作用。
DOI:
10.3390/biom5031515
发表时间:
2015-07-17
期刊:
Biomolecules
影响因子:
5.5
作者:
[Robinson SR, Oliver AW, Chevassut TJ, Newbury SF]
通讯作者:
Newbury SF
共 7 条
Unlocking the molecular and cellular mechanisms regulated by the ribonuclease Dis3L2 in Drosophila and human cell proliferation.
-
批准号:BB/V001701/1
-
项目类别:Research Grant
-
资助金额:$60.49万
-
财政年份:2021
-
负责人:Sarah Newbury
-
依托单位:
Understanding the cellular pathways regulated by Dis3L2 in cell proliferation.
-
批准号:BB/P021042/1
-
项目类别:Research Grant
-
资助金额:$54.57万
-
财政年份:2018
-
负责人:Sarah Newbury
-
依托单位:
Epigenetic regulation of gene expression by the exoribonuclease pacman
-
批准号:BB/I021345/1
-
项目类别:Research Grant
-
资助金额:$56.98万
-
财政年份:2011
-
负责人:Sarah Newbury
-
依托单位:
Function of the exoribonuclease pacman in cell movement and cell shape change
-
批准号:BB/G002754/1
-
项目类别:Research Grant
-
资助金额:$53.28万
-
财政年份:2008
-
负责人:Sarah Newbury
-
依托单位:
Analysis of the role of ribonucleases in the regulation of epithelial sheet sealing
-
批准号:BB/C005163/2
-
项目类别:Research Grant
-
资助金额:$19.34万
-
财政年份:2007
-
负责人:Sarah Newbury
-
依托单位:
国内基金
海外基金
登录
查看更多内容
慢性乙肝功能性治愈mRNA药物专利转让
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵维俊
-
依托单位:
靶向子宫内膜癌的GCNT3 mRNA聚合物纳米递送系统的构建及转化研究
-
批准号:JCZRLH202601886
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
YBX1介导的HOXA9 mRNA稳定性影响c-MYC转录在胃癌进展中的机制研究
-
批准号:2026JJ82359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:卢太亮
-
依托单位:
TET1介导GLI3 mRNA m5C去甲基化修饰负调控ABCA1促动脉粥样硬化
-
批准号:2026JJ81712
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜滢
-
依托单位:
基于mRNA的可调控MSLN-IL-12-CAR T联合表达Mesothelin的溶瘤病毒协同提高对非小细胞肺癌杀伤活性的研究
-
批准号:JCZRMS202601676
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
PUS7介导PCGF5 mRNA假尿苷修饰下调DUSP2表达促进甲状腺未分化癌增殖与转移的机制研究
-
批准号:2026JJ70014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:丁颖
-
依托单位:
基于原位凝胶-LNP复合递送系统的mRNA长效释放机制与效能研究
-
批准号:2026JJ70076
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈启明星
-
依托单位:
清瘟败毒饮通过YBX1/m5C介导的PKM2/LDHA mRNA稳定性下调抑制糖酵解及M1巨噬细胞极化减轻脓毒症肺损伤的机制研究
-
批准号:2026JJ82076
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗柔
-
依托单位:
α-酮戊二酸抑制NSUN2介导GATA4 mRNA m5C修饰调控血管平滑肌细胞衰老相关分泌表型及动脉粥样硬化
-
批准号:2026JJ81921
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谈春芝
-
依托单位:
TRIM25抑制YBX1-m5C介导的TIGAR mRNA稳定调控缺血性脑卒中神经元铁死亡的机制探索
-
批准号:2026JJ81956
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李燕
-
依托单位: